Skip to main content
INSM
NASDAQ Life Sciences

Sanofi Weighs Takeover Bid for Insmed, Bloomberg Reports

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$128.03
Mkt Cap
$28.087B
52W Low
$90.39
52W High
$212.75
52W Position info
42% above low
Off High info
40% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

INSM sits 42% above its 52-week low of $90.39 on light trading volume (0.2× avg).

Summary

Bloomberg reports Sanofi is weighing a takeover of Insmed, a US biotech with a fast-growing bronchiectasis franchise. Insmed's Q3 revenue hit $524.4 million, up 268% year over year, on $398.1 million of US BRINSUPRI sales, and the company raised full-year guidance — a commercial profile that makes it a credible strategic target for a large pharma buyer. The report is early-stage: no price, no confirmed talks, and no Sanofi confirmation, so the terms and certainty are unknown. Insmed's board also added Paul Hudson, Sanofi's former CEO, in October, which gives the two companies an existing high-level link.

At the time of this announcement, INSM was trading at $128.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.1B. The 52-week trading range was $90.39 to $212.75. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

INSM - Latest Insights

INSM
Oct 30, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $110.91
Real-time Price: $128.03 info
Change: +$17.12 (+15%) info
Market Cap: $28.087B info
INSM
Oct 29, 2026, 12:51 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $110.63
Real-time Price: $128.03 info
Change: +$17.40 (+16%) info
Market Cap: $28.087B info
INSM
Oct 29, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $128.03 info
Change: +$29.26 (+30%) info
Market Cap: $28.087B info
INSM
Oct 29, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $128.03 info
Change: +$29.26 (+30%) info
Market Cap: $28.087B info
INSM
Oct 15, 2026, 8:54 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $96.60
Real-time Price: $128.03 info
Change: +$31.43 (+33%) info
Market Cap: $28.087B info